American Journal of Obstetrics & Gynecology
Volume 203, Issue 3 , Pages 246.e1-246.e4 , September 2010

Association of midgestation paraoxonase 1 activity and pregnancies complicated by preterm birth

Presented at the 30th Annual Meeting of the Society for Maternal-Fetal Medicine, Chicago, IL, Feb. 1-6, 2010.

  • Arthur M. Baker, MD

      Affiliations

    • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC
    • Corresponding Author InformationReprints: Arthur M. Baker, MD, Department of Obstetrics and Gynecology, University of North Carolina, 3010 Old Clinic Building, CB#7516, Chapel Hill, NC 27599-7516
    • ,
  • Sina Haeri, MD, MHSA

      Affiliations

    • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC
    • ,
  • Richard L. Klein, PhD

      Affiliations

    • Division of Endocrinology, Metabolism, and Medical Genetics, Department of Medicine, Medical University of South Carolina, and Research Service, Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, SC
    • ,
  • Kim Boggess, MD

      Affiliations

    • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC

Received 8 February 2010 ,Revised 13 April 2010 ,Accepted 29 April 2010.

References 

  1. Wilcox AJ, Skjaerven R. Birth weight and perinatal mortality: the effect of gestational age. Am J Pub Health. 1992;82:378–382
  2. Berkowitz GS, Papiernik E. Epidemiology of preterm birth. Epidemiol Rev. 1993;15:414–443
  3. Clements KM, Barfield WD, Avadi MF, Wilber N. Preterm birth-associated cost of early intervention services: an analysis by gestational age. Pediatrics. 2007;119:866–874
  4. Grimes DA, Schulz KF. Randomized controlled trial of home uterine activity monitoring: a review and critique. Obstet Gynecol. 1992;79:137–142
  5. Shiono PH, Klebanoff MA. A review of risk scoring for preterm birth. Clin Perinatol. 1993;20:107–125
  6. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med. 1995;333:1732–1736
  7. Meis PJ, Klebanoff M, Thom E, et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Eng J Med. 2003;348:2379–2385
  8. Irgens H, Reisaeter L, Irgens L, Lie R. Long term mortality of mothers and fathers after preeclampsia: population based cohort. BMJ. 2001;323:1213–1217
  9. Catov JM, Newman AM, Roberts JM, et al. Preterm delivery and later maternal cardiovascular disease risk. Epidemiology. 2007;18:733–739
  10. Catov JM, Bodnar LM, Ness RB, Barron SJ, Roberts JM. Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol. 2007;166:1312–1319
  11. Chen X, Scholl TO. Association of elevated free fatty acids during late pregnancy with preterm delivery. Obstet Gynecol. 2008;112:297–303
  12. Lawlor DA, Gaunt TR, Hinks LJ, et al. The association of the PON 1 Q192R polymorphism with complications and outcomes of pregnancy: findings from the British Women's Heart and Health cohort study. Paediatr Perinat Epidemiol. 2006;20:244–250
  13. Chen D, Hu Y, Chen C, et al. Polymorphisms of the paraoxonase gene and risk of preterm delivery. Epidemiology. 2004;15:466–470
  14. Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol. 2005;69:541–550
  15. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2001;21:473–480
  16. Mackness B, Durrington P, McElduff P, et al. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation. 2003;107:2775–2779
  17. Mackness MI, Harty D, Bhatnagar D, et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis. 1991;86:193–199
  18. Mackness B, Mackness MI, Arrol S, et al. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis. 1998;139:341–349
  19. Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase: evidence for one esterase catalyzing both activities. Drug Metab Dispos. 1991;19:100–106
  20. Mackness MI, Arrol S, Mackness B, Durrington PN. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoproteins against lipid peroxidation. Lancet. 1997;349:851–852
  21. Costa L, Cole T, Jarvik G, Furlong C. Functional genomics of the paraoxonase (PON 1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu Rev Med. 2003;54:371–392
  22. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2001;21:473–480
  23. Mackness B, Davies GK, Turkie W, et al. Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?. Aterioscler Thromb Vasc Biol. 2001;21:1451–1457
  24. Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol. 2005;69:541–550
  25. Craig SR, Amin RV, Russell DW, Paradise NF. Blood cholesterol screening influence of fasting state on cholesterol results and management decisions. J Gen Intern Med. 2000;15:395–399
  26. Schaefer EJ, Audelin MC, McNamara JR, et al. Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease. Am J Cardiol. 2001;88:1129–1133

 This study was supported in part by grants from the University of North Carolina Medical Alumni Endowment Fund (to A.M.B.), the North Carolina Translational and Clinical Sciences Institute (to A.M.B.), and a Department of Veterans Affairs MERIT award (to R.L.K.).

 Cite this article as: Baker AM, Haeri S, Klein RL, et al. Association of midgestation paraoxonase 1 activity and pregnancies complicated by preterm birth. Am J Obstet Gynecol 2010;203:246.e1-4.

PII: S0002-9378(10)00564-8

doi: 10.1016/j.ajog.2010.04.048

American Journal of Obstetrics & Gynecology
Volume 203, Issue 3 , Pages 246.e1-246.e4 , September 2010

Article Tools